Anaphylaxis after zoster vaccine: Implicating alpha-gal allergy as a possible mechanism

Gelatin and other nonprimate mammal-derived products are common excipient ingredients in several vaccines,2,3 and it has been postulated that patients with alpha-gal allergy might react to these vaccines.4 A patient in our clinic with a documented history of red meat allergy since November 2008 requ...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 139; no. 5; pp. 1710 - 1713.e2
Main Authors Stone, Cosby A., Hemler, Jonathan A., Commins, Scott P., Schuyler, Alexander J., Phillips, Elizabeth J., Peebles, R. Stokes, Fahrenholz, John M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.05.2017
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Gelatin and other nonprimate mammal-derived products are common excipient ingredients in several vaccines,2,3 and it has been postulated that patients with alpha-gal allergy might react to these vaccines.4 A patient in our clinic with a documented history of red meat allergy since November 2008 required emergency department treatment and epinephrine administration on receipt of live attenuated herpes zoster vaccine containing the Oka varicella zoster virus strain in September 2014. There was also low positive binding (values, 0.27-0.45 IU/mL) for MMR and zoster vaccine in sera from subjects A and B that could be removed by the presence of bovine thyroglobulin, although sera from subject C did not demonstrate binding to any of the candidate vaccines. To ascertain the presence of vaccine epitopes that would bind/remove alpha-gal-specific IgE in excess of that expected for gelatin alone, we incubated serum samples from the index patient and the 3 subjects with positive alpha-gal results overnight separately with 100 μg from each of the 5 vaccines, bovine gelatin, and porcine gelatin and remeasured alpha-gal IgE titers. Reported sIgE levels were as follows: porcine gelatin, 0.58 kU/L; bovine gelatin, <0.10 kU/L; and alpha-gal, 3.70 kU/L Maryland References 1 S. Commins, S.M. Satinover, J. Hosen, L. Mozena, L. Borish, B.D. Lewis, Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose, J Allergy Clin Immunol, Vol. 123, 2009, 426-433 2 J. Kelso, M. Greenhawt, J. Li, R. Nicklas, D. Bernstein, J. Blessing-Moore, Adverse reactions to vaccines practice parameter...
AbstractList Gelatin and other nonprimate mammal-derived products are common excipient ingredients in several vaccines,2,3 and it has been postulated that patients with alpha-gal allergy might react to these vaccines.4 A patient in our clinic with a documented history of red meat allergy since November 2008 required emergency department treatment and epinephrine administration on receipt of live attenuated herpes zoster vaccine containing the Oka varicella zoster virus strain in September 2014. There was also low positive binding (values, 0.27-0.45 IU/mL) for MMR and zoster vaccine in sera from subjects A and B that could be removed by the presence of bovine thyroglobulin, although sera from subject C did not demonstrate binding to any of the candidate vaccines. To ascertain the presence of vaccine epitopes that would bind/remove alpha-gal-specific IgE in excess of that expected for gelatin alone, we incubated serum samples from the index patient and the 3 subjects with positive alpha-gal results overnight separately with 100 μg from each of the 5 vaccines, bovine gelatin, and porcine gelatin and remeasured alpha-gal IgE titers. Reported sIgE levels were as follows: porcine gelatin, 0.58 kU/L; bovine gelatin, <0.10 kU/L; and alpha-gal, 3.70 kU/L Maryland References 1 S. Commins, S.M. Satinover, J. Hosen, L. Mozena, L. Borish, B.D. Lewis, Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose, J Allergy Clin Immunol, Vol. 123, 2009, 426-433 2 J. Kelso, M. Greenhawt, J. Li, R. Nicklas, D. Bernstein, J. Blessing-Moore, Adverse reactions to vaccines practice parameter...
A patient with alpha-gal allergy presented with anaphylaxis after receiving zoster vaccine. Subsequent testing of selected vaccines revealed the presence of alpha-gal allergen in MMR and zoster vaccines, which have in common a higher content of gelatin and content of bovine calf serum.
Author Hemler, Jonathan A.
Phillips, Elizabeth J.
Stone, Cosby A.
Schuyler, Alexander J.
Fahrenholz, John M.
Peebles, R. Stokes
Commins, Scott P.
AuthorAffiliation Division of Rheumatology, Allergy & Immunology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Department of Pharmacology, Vanderbilt University School of Medicine
Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine
ˆ Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, Western Australia 6150
Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Asthma and Allergic Disease Center, Carter Immunology Center, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA
Allergy and Immunology Section, Medical Service, Veterans Administration Medical Center, Tennessee Valley Healthcare System, Nashville, Tennessee, USA
AuthorAffiliation_xml – name: Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
– name: ˆ Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, Western Australia 6150
– name: Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine
– name: Division of Rheumatology, Allergy & Immunology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
– name: Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
– name: Allergy and Immunology Section, Medical Service, Veterans Administration Medical Center, Tennessee Valley Healthcare System, Nashville, Tennessee, USA
– name: Department of Pharmacology, Vanderbilt University School of Medicine
– name: Asthma and Allergic Disease Center, Carter Immunology Center, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA
Author_xml – sequence: 1
  givenname: Cosby A.
  surname: Stone
  fullname: Stone, Cosby A.
  email: cosby.a.stone@vanderbilt.edu
  organization: Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
– sequence: 2
  givenname: Jonathan A.
  surname: Hemler
  fullname: Hemler, Jonathan A.
  organization: Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
– sequence: 3
  givenname: Scott P.
  surname: Commins
  fullname: Commins, Scott P.
  organization: Division of Rheumatology, Allergy & Immunology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC
– sequence: 4
  givenname: Alexander J.
  surname: Schuyler
  fullname: Schuyler, Alexander J.
  organization: Asthma and Allergic Disease Center, Carter Immunology Center, Department of Medicine, University of Virginia Health System, Charlottesville, Va
– sequence: 5
  givenname: Elizabeth J.
  surname: Phillips
  fullname: Phillips, Elizabeth J.
  organization: Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
– sequence: 6
  givenname: R. Stokes
  surname: Peebles
  fullname: Peebles, R. Stokes
  organization: Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
– sequence: 7
  givenname: John M.
  surname: Fahrenholz
  fullname: Fahrenholz, John M.
  organization: Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27986511$$D View this record in MEDLINE/PubMed
BookMark eNqFUl1r3DAQFCWluaT9A30ohj77IsmWZYcSCKFtAoE8tKWPQl6v7-TKsiv5jl5_fWUuH20gKQh2tdqZXWZ0RA7c4JCQt4wuGWXFSbfsNJglj3ksLGkmX5AFo5VMi5KLA7KgtGJpIfPqkByF0NF4z8rqFTnksioLwdiCfD93elzvrP5lQqLbCX3yewhz2GoA4_A0uepHa0BPxq0Sbce1TlfaxsyiX-0SHWHJOIRgaotJj7DWzoT-NXnZahvwzW08Jt8-ffx6cZle33y-uji_TkEwPqUtygYqmTHgEgXIvNAZFsBo0_J4WpZluYQMeFk3TQW1RqQ5q4FqUcii0dkxOdvzjpu6xwbQTV5bNXrTa79Tgzbq3xdn1mo1bJXIOc1LEQne3xL44ecGw6S6YeNd3FmxshKCUlaVsevd32Pu-e-EjA183wA-auGxvW9hVM1uqU7NbqnZrbkW3Yqg8hEIzBSFHuZVjX0e-mEPxSju1qBXAQw6wMZ4hEk1g3kefvYIDta46LL9gTsMDxKowBVVX-afNH8kVmQsF2KW7fRpgv9N_wOcz9pU
CitedBy_id crossref_primary_10_1016_j_jaci_2020_01_047
crossref_primary_10_1007_s11882_019_0835_9
crossref_primary_10_1007_s11894_022_00860_7
crossref_primary_10_1016_j_jaip_2017_09_023
crossref_primary_10_1016_j_talanta_2024_125851
crossref_primary_10_1016_j_anai_2019_07_017
crossref_primary_10_1016_j_jaip_2024_11_010
crossref_primary_10_1097_IIO_0000000000000330
crossref_primary_10_2147_ITT_S276872
crossref_primary_10_29262_ram_v69iSupl1_989
crossref_primary_10_1016_j_aller_2019_07_004
crossref_primary_10_1007_s40521_022_00313_6
crossref_primary_10_1016_j_jaad_2023_04_054
crossref_primary_10_3390_medicina55080501
crossref_primary_10_1016_j_jaip_2021_03_002
crossref_primary_10_1007_s15007_019_1858_1
crossref_primary_10_1007_s40629_019_0094_2
crossref_primary_10_1016_j_amjms_2024_11_015
crossref_primary_10_1001_jama_2023_26857
crossref_primary_10_1111_pai_12762
crossref_primary_10_3390_vaccines10020269
crossref_primary_10_1213_ANE_0000000000003460
crossref_primary_10_1016_j_iac_2021_12_008
crossref_primary_10_1002_jmv_27022
crossref_primary_10_1159_000503966
crossref_primary_10_4158_ACCR_2019_0495
crossref_primary_10_5694_mja17_00591
crossref_primary_10_1016_j_jaip_2019_12_004
crossref_primary_10_1111_cea_13683
crossref_primary_10_1016_j_jaci_2017_08_047
crossref_primary_10_3390_ijerph192416716
crossref_primary_10_1016_j_molimm_2018_03_018
crossref_primary_10_1016_j_jaip_2023_05_004
crossref_primary_10_4274_tpd_galenos_2024_97720
crossref_primary_10_1371_journal_pone_0235076
crossref_primary_10_3389_fimmu_2024_1335911
crossref_primary_10_1016_j_anai_2019_03_021
crossref_primary_10_1055_a_1353_1387
crossref_primary_10_1016_j_anai_2022_01_026
crossref_primary_10_3389_falgy_2025_1535103
crossref_primary_10_1016_j_jaci_2017_12_971
crossref_primary_10_1080_0194262X_2019_1645079
crossref_primary_10_1111_bcp_14080
crossref_primary_10_1080_1744666X_2020_1782745
crossref_primary_10_1016_j_reval_2021_01_005
crossref_primary_10_3390_vaccines12010065
crossref_primary_10_1111_bcp_14112
crossref_primary_10_1016_j_jaip_2023_05_015
crossref_primary_10_1016_j_reval_2018_02_187
crossref_primary_10_1007_s40278_019_61883_2
crossref_primary_10_1159_000514263
crossref_primary_10_1016_j_jaip_2018_06_005
crossref_primary_10_1016_j_biomaterials_2021_121029
crossref_primary_10_1016_j_jaip_2018_12_005
crossref_primary_10_7759_cureus_24551
crossref_primary_10_1136_bcr_2021_245488
crossref_primary_10_7759_cureus_53208
crossref_primary_10_1007_s40521_017_0134_4
crossref_primary_10_1016_j_jaip_2019_09_017
Cites_doi 10.1067/mai.2000.108433
10.1016/j.vaccine.2015.01.020
10.1111/j.1365-2796.2011.02474.x
10.1016/j.jaci.2008.10.052
10.1007/s12245-009-0093-z
10.1016/j.jaci.2012.04.003
10.1016/j.jaci.2012.02.038
10.1016/j.vaccine.2007.02.064
10.1056/NEJMoa051016
ContentType Journal Article
Copyright 2016 American Academy of Allergy, Asthma & Immunology
American Academy of Allergy, Asthma & Immunology
Copyright Elsevier Science Ltd. May 1, 2017
Copyright_xml – notice: 2016 American Academy of Allergy, Asthma & Immunology
– notice: American Academy of Allergy, Asthma & Immunology
– notice: Copyright Elsevier Science Ltd. May 1, 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
5PM
DOI 10.1016/j.jaci.2016.10.037
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Entomology Abstracts (Full archive)
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Entomology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
DatabaseTitleList Entomology Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6825
EndPage 1713.e2
ExternalDocumentID PMC5420485
27986511
10_1016_j_jaci_2016_10_037
S0091674916314555
1_s2_0_S0091674916314555
Genre Letter
Research Support, Non-U.S. Gov't
Case Reports
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R21 AI087985
– fundername: NIGMS NIH HHS
  grantid: P50 GM115305
– fundername: NIAID NIH HHS
  grantid: R01 AI135049
– fundername: NIAID NIH HHS
  grantid: P30 AI110527
– fundername: NIAID NIH HHS
  grantid: R56 AI113095
– fundername: NIAID NIH HHS
  grantid: R01 AI103348
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
AACTN
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
5PM
ID FETCH-LOGICAL-c512t-fe7dc9731c27e5c746a3e6c10df2df2f13347c3c28bdd9cbaee041bc0a5676da3
IEDL.DBID .~1
ISSN 0091-6749
IngestDate Thu Aug 21 18:17:40 EDT 2025
Wed Aug 13 05:10:29 EDT 2025
Mon Jul 21 05:51:58 EDT 2025
Tue Jul 01 00:47:24 EDT 2025
Thu Apr 24 22:55:29 EDT 2025
Sun Apr 06 06:53:19 EDT 2025
Wed Apr 02 07:27:50 EDT 2025
Tue Aug 26 16:31:57 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c512t-fe7dc9731c27e5c746a3e6c10df2df2f13347c3c28bdd9cbaee041bc0a5676da3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
PMID 27986511
PQID 1895500198
PQPubID 105664
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5420485
proquest_journals_1895500198
pubmed_primary_27986511
crossref_primary_10_1016_j_jaci_2016_10_037
crossref_citationtrail_10_1016_j_jaci_2016_10_037
elsevier_sciencedirect_doi_10_1016_j_jaci_2016_10_037
elsevier_clinicalkeyesjournals_1_s2_0_S0091674916314555
elsevier_clinicalkey_doi_10_1016_j_jaci_2016_10_037
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-05-01
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: 2017-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: St. Louis
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 2017
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References Vaccine excipient & media summary. Centers for Disease Control and Prevention; 2015. Available at
Manivannan, Decker, Stead, Li, Campbell (bib5) 2009; 2
Search the VAERS Database. 2016. Available at
Mullins, James, Platts-Mills, Commins (bib7) 2012; 129
Kelso, Greenhawt, Li, Nicklas, Bernstein, Blessing-Moore (bib2) 2012; 130
Pinson, Waibel (bib4) 2015; 33
Accessed May 20, 2016.
Accessed June 5, 2016.
Commins, Satinover, Hosen, Mozena, Borish, Lewis (bib1) 2009; 123
Tseng, Liu, Sy, Marcy, Fireman, Weintraub (bib8) 2012; 271
Commins (10.1016/j.jaci.2016.10.037_bib1) 2009; 123
10.1016/j.jaci.2016.10.037_bib6
10.1016/j.jaci.2016.10.037_bib3
Tseng (10.1016/j.jaci.2016.10.037_bib8) 2012; 271
Kelso (10.1016/j.jaci.2016.10.037_bib2) 2012; 130
Pinson (10.1016/j.jaci.2016.10.037_bibE5) 2015; 33
Manivannan (10.1016/j.jaci.2016.10.037_bib5) 2009; 2
Oxman (10.1016/j.jaci.2016.10.037_bibE4) 2005; 352
Mullins (10.1016/j.jaci.2016.10.037_bib7) 2012; 129
Rüggeberg (10.1016/j.jaci.2016.10.037_bibE1) 2007; 25
Mullins (10.1016/j.jaci.2016.10.037_bibE2) 2012; 129
Pinson (10.1016/j.jaci.2016.10.037_bib4) 2015; 33
Nakayama (10.1016/j.jaci.2016.10.037_bibE3) 2000; 106
29370925 - J Allergy Clin Immunol. 2018 May;141(5):1957-1958. doi: 10.1016/j.jaci.2017.08.048
29361333 - J Allergy Clin Immunol. 2018 May;141(5):1956-1957. doi: 10.1016/j.jaci.2017.08.047
References_xml – volume: 271
  start-page: 510
  year: 2012
  end-page: 520
  ident: bib8
  article-title: Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study
  publication-title: J Intern Med
– volume: 123
  start-page: 426
  year: 2009
  end-page: 433
  ident: bib1
  article-title: Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose
  publication-title: J Allergy Clin Immunol
– reference: Search the VAERS Database. 2016. Available at:
– volume: 33
  start-page: 1231
  year: 2015
  end-page: 1232
  ident: bib4
  article-title: Safe administration of a gelatin-containing vaccine in an adult with galactose-α-1,3-galactose allergy
  publication-title: Vaccine
– reference: Vaccine excipient & media summary. Centers for Disease Control and Prevention; 2015. Available at:
– volume: 130
  start-page: 25
  year: 2012
  end-page: 43
  ident: bib2
  article-title: Adverse reactions to vaccines practice parameter update
  publication-title: J Allergy Clin Immunol
– reference: . Accessed June 5, 2016.
– volume: 2
  start-page: 3
  year: 2009
  end-page: 5
  ident: bib5
  article-title: Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxis
  publication-title: Int J Emerg Med
– reference: . Accessed May 20, 2016.
– volume: 129
  start-page: 1334
  year: 2012
  end-page: 1342
  ident: bib7
  article-title: Relationship between red meat allergy and sensitization to gelatin and galactose-α-1,3-galactose
  publication-title: J Allergy Clin Immunol
– volume: 106
  start-page: 591
  year: 2000
  ident: 10.1016/j.jaci.2016.10.037_bibE3
  article-title: Change in gelatin content of vaccines associated with reduction in reports of allergic reactions
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2000.108433
– volume: 33
  start-page: 1231
  year: 2015
  ident: 10.1016/j.jaci.2016.10.037_bib4
  article-title: Safe administration of a gelatin-containing vaccine in an adult with galactose-α-1,3-galactose allergy
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.01.020
– volume: 271
  start-page: 510
  year: 2012
  ident: 10.1016/j.jaci.2016.10.037_bib8
  article-title: Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2011.02474.x
– volume: 123
  start-page: 426
  year: 2009
  ident: 10.1016/j.jaci.2016.10.037_bib1
  article-title: Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2008.10.052
– volume: 33
  start-page: 1231
  year: 2015
  ident: 10.1016/j.jaci.2016.10.037_bibE5
  article-title: Safe administration of a gelatin-containing vaccine in an adult with galactose-α-1,3-galactose allergy
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.01.020
– volume: 2
  start-page: 3
  year: 2009
  ident: 10.1016/j.jaci.2016.10.037_bib5
  article-title: Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxis
  publication-title: Int J Emerg Med
  doi: 10.1007/s12245-009-0093-z
– volume: 130
  start-page: 25
  year: 2012
  ident: 10.1016/j.jaci.2016.10.037_bib2
  article-title: Adverse reactions to vaccines practice parameter update
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2012.04.003
– volume: 129
  start-page: 1334
  year: 2012
  ident: 10.1016/j.jaci.2016.10.037_bib7
  article-title: Relationship between red meat allergy and sensitization to gelatin and galactose-α-1,3-galactose
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2012.02.038
– volume: 25
  start-page: 5675
  year: 2007
  ident: 10.1016/j.jaci.2016.10.037_bibE1
  article-title: Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.02.064
– volume: 129
  start-page: 1334
  year: 2012
  ident: 10.1016/j.jaci.2016.10.037_bibE2
  article-title: Relationship between red meat allergy and sensitization to gelatin and galactose-α-1,3-galactose
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2012.02.038
– ident: 10.1016/j.jaci.2016.10.037_bib6
– volume: 352
  start-page: 2271
  year: 2005
  ident: 10.1016/j.jaci.2016.10.037_bibE4
  article-title: A vaccine to prevent herpes zoster in older adults
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa051016
– ident: 10.1016/j.jaci.2016.10.037_bib3
– reference: 29361333 - J Allergy Clin Immunol. 2018 May;141(5):1956-1957. doi: 10.1016/j.jaci.2017.08.047
– reference: 29370925 - J Allergy Clin Immunol. 2018 May;141(5):1957-1958. doi: 10.1016/j.jaci.2017.08.048
SSID ssj0009389
Score 2.4766572
Snippet Gelatin and other nonprimate mammal-derived products are common excipient ingredients in several vaccines,2,3 and it has been postulated that patients with...
A patient with alpha-gal allergy presented with anaphylaxis after receiving zoster vaccine. Subsequent testing of selected vaccines revealed the presence of...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1710
SubjectTerms Allergens - immunology
Allergies
Allergy and Immunology
Anaphylaxis
Anaphylaxis - diagnosis
Anaphylaxis - etiology
Angioedema
Antibodies
Antigens
Beef
Chicken pox
Drug-Related Side Effects and Adverse Reactions - diagnosis
Emergency medical care
Emergency Medical Services
Epinephrine
Epinephrine - administration & dosage
Epitopes
Excipients - adverse effects
Female
Galactose
Galactose - analogs & derivatives
Galactose - immunology
Gelatin
Gelatin - immunology
Herpes zoster
Herpes Zoster Vaccine - adverse effects
Herpes Zoster Vaccine - immunology
Humans
Hypersensitivity - complications
Hypersensitivity - diagnosis
Immunity, Heterologous
Immunoglobulin E
Immunoglobulin E - blood
Mammals
Meat
Middle Aged
Patients
Pharmacy
Side effects
Thyroglobulin
Urticaria
Vaccines
Varicella
Vital signs
Title Anaphylaxis after zoster vaccine: Implicating alpha-gal allergy as a possible mechanism
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0091674916314555
https://www.clinicalkey.es/playcontent/1-s2.0-S0091674916314555
https://dx.doi.org/10.1016/j.jaci.2016.10.037
https://www.ncbi.nlm.nih.gov/pubmed/27986511
https://www.proquest.com/docview/1895500198
https://pubmed.ncbi.nlm.nih.gov/PMC5420485
Volume 139
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQSFUvVelzKSAfeqsCcezYSW8rBFpawamo3Cy_QoOWsNpsEe2hv70zibN0C6JSlSgHZ0Z2JmPPWP5mhpD3YEVSrgLMNBFcIrgvk5LLKrFCFhXYNy-6E92TUzk5E5_O8_M1cjDEwiCsMq79_ZrerdaxZT9Kc39W1xjjWyKEHh4cs21joLkQCrV879cdzKPkRe8ClyxB6hg402O8Lo2rEd4l9xDhhbXQHzZO953PvzGUfxilo-fkWfQm6bgf8CZZC80L8uQknpe_JF_HDeajnprbuqVdOXD6E6M65vTGOCT5SI8HSHlzQbvA2wRsBsUKK_OLH9QAG51d48SZBnoVME64bq9ekbOjwy8HkySWUkgcWPRFUgXlHVapcpkKuVNCGh6kY6mvMrgr2KkK5bjLCut96awJIRXMutTkUklv-Guy3lw34S2hxvpSBFYF7hn832At81VhDbMZXKkZETbIULuYZxzLXUz1ACi71Ch3jXLHNpD7iHxY8sz6LBuPUvPh1-ghfhRWPA1G4FEu9RBXaOOkbTXTbaZTfU-xRiRfcq7o5j973B70Rt91UpSwKQTHuhiRN70KLT85U2UhwQOGoa4o15IAc4Gvvmnqb11O8FxgBuZ86z-H-o48zdBf6ZCc22R9Mf8edsDbWtjdbjrtko3x8efJ6W_YvSsG
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VVAIuiDeBAnvghkxt7_rFLaqoEtrk1IreVvtycZW6UZxWwK9nxl6nhFZFQrZ8sHe06_Hszqz8zTcAH9CLhDxzONOEM4HgtggKnpaBFmleon-zov2jO52l42Px9SQ52YK9PheGYJV-7e_W9Ha19nd2vTZ3F1VFOb4FQejxwoltO7kH28ROlQxgezQ5GM-uuXd53kXBRRSQgM-d6WBeZ8pUhPBKPxHIi8qh3-6fbsaff8Mo__BL-4_hkQ8o2agb8xPYcvVTuD_1v8yfwbdRTZTUc_WjalhbEZz9osSOJbtShpp8ZpMeVV6fsjb3NkC3wajIyvL0J1MoxhYXNHfmjp07ShWumvPncLz_5WhvHPhqCoFBp74KSpdZQ4WqTJy5xGQiVdylJgptGeNZ4mZVZIabONfWFkYr50IRaROqJM1Sq_gLGNQXtXsFTGlbCBeVjtsIP7HTOrJlrlWkYzxCNYSo16E0nmqcKl7MZY8pO5Okd0l6p3uo9yF8XMssOqKNO1vz_tPIPoUUFz2JfuBOqew2Kdf4edvISDaxDOUN2xpCspbcMM9_9rjT24287iQvcF-IsXU-hJedCa1fOc6KPMUgGIe6YVzrBkQHvvmkrr63tOCJIBLm5PV_DvU9PBgfTQ_l4WR28AYexhS-tMDOHRislpfuLQZfK_3OT67f-PEttw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anaphylaxis+after+zoster+vaccine%3A+Implicating+alpha-gal+allergy+as+a+possible+mechanism&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Stone%2C+Cosby+A.&rft.au=Hemler%2C+Jonathan+A.&rft.au=Commins%2C+Scott+P.&rft.au=Schuyler%2C+Alexander+J.&rft.date=2017-05-01&rft.pub=Elsevier+Inc&rft.issn=0091-6749&rft.volume=139&rft.issue=5&rft.spage=1710&rft.epage=1713.e2&rft_id=info:doi/10.1016%2Fj.jaci.2016.10.037&rft.externalDocID=S0091674916314555
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6749&client=summon